ÅǸ޴º
Á¦¸ñ | A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson¡¯s disease, in healthy volunteers, 2019-02-18, Drug design, development and therapy | µî·ÏÀÏ | 20200928 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson¡¯s disease, in healthy volunteers, 2019-02-18, Drug design, development and therapy
|
Copyright ¨Ï chamc, All rights reserved.